|
L-NMMA . monoacetate |
|
|
ALX-106-001-M005 |
|
5 mg |
20.00 USD |
|
 |
|
ALX-106-001-M025 |
|
25 mg |
55.00 USD |
|
|
|
ALX-106-001-M100 |
|
100 mg |
180.00 USD |
|
|
|
ALX-106-001-G001 |
|
1 g |
360.00 USD |
|
|
|
|
D-NMMA . monoacetate |
|
|
ALX-106-002-M005 |
|
5 mg |
27.00 USD |
|
|
|
ALX-106-002-M025 |
|
25 mg |
100.00 USD |
|
|
|
ALX-106-002-M100 |
|
100 mg |
280.00 USD |
|
|
|
|
NG, NG-Dimethyl-L-arginine . di(p-hydroxyazobenzene-p'-sulfonate) |
|
|
ALX-106-005-M005 |
|
5 mg |
23.00 USD |
|
|
|
ALX-106-005-M025 |
|
25 mg |
55.00 USD |
|
|
|
|
NG, NG-Dimethyl-L-arginine . dihydrochloride |
|
|
ALX-106-006-M005 |
|
5 mg |
33.00 USD |
|
|
|
ALX-106-006-M025 |
|
25 mg |
85.00 USD |
|
|
|
|
NG, N'G-Dimethyl-L-arginine . di(p-hydroxyazobenzene-p'-sulfonate) |
|
|
ALX-106-007-M005 |
|
5 mg |
23.00 USD |
|
|
|
ALX-106-007-M025 |
|
25 mg |
55.00 USD |
|
|
|
|
NG, N'G-Dimethyl-L-arginine . dihydrochloride |
|
|
ALX-106-008-M005 |
|
5 mg |
33.00 USD |
|
|
|
ALX-106-008-M025 |
|
25 mg |
85.00 USD |
|
|
|
|
N-Acetyl-Asp-Tyr(2-malonyl)-Val-Pro-Met-Leu-NH2 |
|
|
ALX-151-026-M001 |
|
1 mg |
90.00 USD |
|
|
|
|
N-Acetyl-Asp-Tyr(PO3H2)-Val-Pro-Met-Leu-NH2 |
|
|
ALX-151-027-M001 |
|
1 mg |
90.00 USD |
|
|
|
|
Caveolin-1 Scaffolding Domain Peptide |
|
|
ALX-153-064-M001 |
|
1 mg |
140.00 USD |
|
|
|
ALX-153-064-M005 |
|
5 mg |
560.00 USD |
|
|
|
|
JNK Inhibitor 1 (L-stereoisomer) |
|
|
ALX-159-600-R100 |
|
100 µl |
125.00 USD |
|
|
|
ALX-159-600-R200 |
|
200 µl |
225.00 USD |
|
|
|
|
NBD Peptide / NF-κB Blocker (cell permeable) |
|
|
ALX-163-011-1 |
|
1 Vial |
240.00 USD |
|
|
|
|
SN50 |
|
|
ALX-167-024-C500 |
|
500 µg |
125.00 USD |
|
|
|
|
SN50M Control Peptide |
|
|
ALX-167-025-C500 |
|
500 µg |
125.00 USD |
|
|
|
|
Control Peptide for Prod. No. ALX-159-600 |
|
|
ALX-168-009/1-R050 |
|
50 µl |
40.00 USD |
|
|
|
|
Control Peptide for Prod. No. ALX-159-600 |
|
|
ALX-168-009F-R050 |
FITC |
50 µl |
110.00 USD |
|
|
|
|
Control Peptide for Prod. No. ALX-159-601 |
|
|
ALX-168-010-R025 |
|
25 µl |
95.00 USD |
|
|
|
ALX-168-010F-R025 |
FITC |
25 µl |
145.00 USD |
|
|
|
|
Ubiquitin Aldehyde (human) |
|
|
ALX-200-603-C050 |
|
50 µg |
127.00 USD |
|
|
|
|
HSF1 (human) (recombinant) |
|
|
ALX-201-024-C150 |
|
150 µg |
343.00 USD |
|
|
|
|
SUMO-1 (1-101) (human) (recombinant) |
|
|
ALX-201-044-C250 |
|
250 µg |
250.00 USD |
|
|
|
|
SUMO-1 (1-97) (human) (recombinant) |
|
|
ALX-201-045-C500 |
|
500 µg |
330.00 USD |
|
|
|
|
UbcH9 (recombinant) |
|
|
ALX-201-046-C050 |
|
50 µg |
290.00 USD |
|
|
|
|
Phosphoinositide 3-kinase p110γ (human) (recombinant) |
|
|
ALX-201-055-C010 |
|
10 µg |
330.00 USD |
|
|
|
|
Caspase-1 (active) (human) (recombinant) |
|
|
ALX-201-056-U025 |
|
25 U |
231.00 USD |
|
|
|
ALX-201-056-U100 |
|
100 U |
385.00 USD |
|
|
|
|
MGMT (human) (recombinant) |
|
|
ALX-201-065-R050 |
|
50 µl |
320.00 USD |
|
|
|
|
EGR-1 Protein (human) (recombinant) |
|
|
ALX-201-074-1 |
|
1 Vial |
365.00 USD |
|
|
|
|
EGR-3 Protein (human) (recombinant) |
|
|
ALX-201-075-1 |
|
1 Vial |
395.00 USD |
|
|
|
|
EGR-4 Protein (human) (recombinant) |
|
|
ALX-201-076-1 |
|
1 Vial |
395.00 USD |
|
|
|
|
NEDD8 Precursor (human) (recombinant) |
|
|
ALX-201-084-M001 |
|
1 mg |
238.00 USD |
|
|
|
|
NEDD8 (human) (recombinant) |
|
|
ALX-201-085-C500 |
|
500 µg |
216.00 USD |
|
|
|
|
SUMO-2 (1-103) (human) (recombinant) |
|
|
ALX-201-086-C250 |
|
250 µg |
270.00 USD |
|
|
|
|
SUMO-2 (1-92) (human) (recombinant) |
|
|
ALX-201-087-C500 |
|
500 µg |
360.00 USD |
|
|
|
|
SUMO-3 (1-95) (human) (recombinant) |
|
|
ALX-201-088-C250 |
|
250 µg |
270.00 USD |
|
|
|
|
SUMO-3 (1-93) (human) (recombinant) |
|
|
ALX-201-089-C500 |
|
500 µg |
360.00 USD |
|
|
|
|
SUMO-1 Activating Enzyme (human) (recombinant) |
|
|
ALX-201-090-C010 |
|
10 µg |
295.00 USD |
|
|
|
|
Caspase-5 (active) (human) (recombinant) |
|
|
ALX-201-094-U025 |
|
25 U |
203.00 USD |
|
|
|
ALX-201-094-U100 |
|
100 U |
371.00 USD |
|
|
|
|
Sp1 Protein (human) (recombinant) (HA) |
|
|
ALX-201-106-R050 |
|
50 µl |
377.00 USD |
|
|
|
|
Sp3 Protein (human) (recombinant) (HA) |
|
|
ALX-201-107-R050 |
|
50 µl |
377.00 USD |
|
|
|
|
Phosphoinositide 3-kinase p110α/p85 (bovine) (recombinant) |
|
|
ALX-201-119-C005 |
|
5 µg |
440.00 USD |
|
|
|
 |
|
|
HSP90 (yeast) (recombinant) (His) |
|
|
ALX-201-138-C025 |
|
25 µg |
180.00 USD |
|
|
|
ALX-201-138-C100 |
|
100 µg |
630.00 USD |
|
|
|
|
HtpG (E. coli) (recombinant) |
|
|
ALX-201-146-C025 |
|
25 µg |
155.00 USD |
|
|
|
|
HSP90β (human) (recombinant) |
|
|
ALX-201-147-C025 |
|
25 µg |
155.00 USD |
|
|
|
|
PDIA2 (human) (recombinant) |
|
|
ALX-201-152-C025 |
|
25 µg |
155.00 USD |
|
|
|
|
NEDP1 (human) (recombinant) |
|
|
ALX-201-171-C050 |
|
50 µg |
290.00 USD |
|
|
|
|
SET7/9 (human) (recombinant) |
|
|
ALX-201-178-C100 |
|
100 µg |
125.00 USD |
|
|
|
|
CEBP-α (270-358) (human) (recombinant) (His) |
|
|
ALX-201-199-C100 |
|
100 µg |
220.00 USD |
|
|
|
|
CEBP-γ (39-147) (human) (recombinant) (His) |
|
|
ALX-201-200-C100 |
|
100 µg |
220.00 USD |
|
|
|
|
HSC70 (rat) (recombinant) |
|
|
ALX-201-213-C025 |
|
25 µg |
160.00 USD |
|
|
|
|
CHIP (human) (recombinant) |
|
|
ALX-201-215-C025 |
|
25 µg |
160.00 USD |
|
|
|
|
Hip (human) (recombinant) |
|
|
ALX-201-216-C025 |
|
25 µg |
160.00 USD |
|
|
|
|
Hop (human) (recombinant) |
|
|
ALX-201-218-C025 |
|
25 µg |
170.00 USD |
|
|
|
|
Pin1 (human) (recombinant) |
|
|
ALX-201-221-C100 |
|
100 µg |
325.00 USD |
|
|
|
|
EGR-2 Protein (human) (recombinant) |
|
|
ALX-201-223-1 |
|
1 Vial |
390.00 USD |
|
|
|
|
ETS1 (human) (recombinant) |
|
|
ALX-201-243-C050 |
|
50 µg |
210.00 USD |
|
|
|
|
Calreticulin (rabbit) (recombinant) |
|
|
ALX-201-269-C025 |
|
25 µg |
170.00 USD |
|
|
|
|
HSP40 (human) (recombinant) (His) |
|
|
ALX-201-274-C100 |
|
100 µg |
620.00 USD |
|
|
|
|
CREB Binding Protein (mouse) (recombinant) (His) |
|
|
ALX-201-279-C002 |
|
2 µg |
280.00 USD |
|
|
|
|
PRMT1 (human) (recombinant) (His) |
|
|
ALX-201-282-C002 |
|
2 µg |
280.00 USD |
|
|
|
|
NF-κB (p65) (human) (recombinant) (His) |
|
|
ALX-201-284-C002 |
|
2 µg |
280.00 USD |
|
|
|
|
NF-κB (p50) (human) (recombinant) (His) |
|
|
ALX-201-285-C002 |
|
2 µg |
280.00 USD |
|
